Article

Systematic identification of genomic non-response biomarkers to cancer therapies

2025-10-07

Abstract excerpt

The costs of cancer therapies are rising rapidly across the globe, with novel therapies like targeted treatment and immunotherapies as major contributors, but their effectiveness can be low or uncertain due to limited post market surveillance. Reliable biomarkers to identify patients highly unlikely to respond to cancer therapies represent an increasingly important clinical and societal need, as they could prevent...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3cac635a-72d2-59f9-b508-52dda0fbbc44
DOI: 10.1101/2025.10.06.680777

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Systematic identification of genomic non-response biomarkers to cancer therapiesDOI 10.1101/2025.10.06.680777Read

AI Model for Predicting Anti-PD1 Response in Melanoma Using Multi-Omics BiomarkersSemantic proximity Read

Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future PerspectivesSemantic proximity Read

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeSemantic proximity Read

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic featuresSemantic proximity Read

A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint InhibitorsSemantic proximity Read

Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy.Semantic proximity Read

Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic featuresSemantic proximity Read

Explainable machine learning identifies features and thresholds predictive of immunotherapy responseSemantic proximity Read

CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancerSemantic proximity Read

A machine learning framework for supervised treatment response prediction from tumor transcriptomics: A large-scale pan-cancer studySemantic proximity Read

Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screensSemantic proximity Read

Multi-omics construction of prognostic and immunotherapy-related gene signature and small molecule drug prediction for skin cutaneous melanomaSemantic proximity Read